Improved safety through tamoxifen-regulated induction of cytotoxic genes delivered by Ad vectors for cancer gene therapy
- 25 July 2000
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 7 (15) , 1317-1325
- https://doi.org/10.1038/sj.gt.3301235
Abstract
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.Keywords
This publication has 32 references indexed in Scilit:
- Deregulated c-myc expression in quiescent CHO cells induces target gene transcription and subsequent apoptotic phenotypeCell Research, 1999
- Apoptosis induction by E2F-1 via adenoviral-mediated gene transfer results in growth suppression of head and neck squamous cell carcinoma cell linesCancer Gene Therapy, 1999
- Combination Therapy with Interleukin-2 and Wild-Type p53 Expressed by Adenoviral Vectors Potentiates Tumor Regression in a Murine Model of Breast CancerHuman Gene Therapy, 1998
- Recombinant E1-Deleted Adenovirus-Mediated Gene Therapy for Cancer: Efficacy Studies with p53 Tumor Suppressor Gene and Liver Histology in Tumor Xenograft ModelsHuman Gene Therapy, 1998
- Comparison of the human versus murine cytomegalovirus immediate early gene promoters for transgene expression by adenoviral vectors.Journal of General Virology, 1997
- Human Adenovirus Vectors for Gene Transfer into Mammalian CellsPublished by Elsevier ,1997
- Ecdysone-inducible gene expression in mammalian cells and transgenic mice.Proceedings of the National Academy of Sciences, 1996
- A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteinsNucleic Acids Research, 1995
- An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3.Proceedings of the National Academy of Sciences, 1994
- Endocrine Pharmacology of Antiestrogens as Antitumor Agents*Endocrine Reviews, 1990